These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 11079671)

  • 1. Mode of onset of ventricular fibrillation in patients with Brugada syndrome detected by implantable cardioverter defibrillator therapy.
    Kakishita M; Kurita T; Matsuo K; Taguchi A; Suyama K; Shimizu W; Aihara N; Kamakura S; Yamamoto F; Kobayashi J; Kosakai Y; Ohe T
    J Am Coll Cardiol; 2000 Nov; 36(5):1646-53. PubMed ID: 11079671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Premature ventricular complexes as a trigger for ventricular fibrillation.
    Sánchez Muñoz JJ; García-Alberola A; Martínez-Sánchez J; Peñafiel-Verdú P; Caro-Martínez C; Manzano-Fernández S; Valdés Chávarri M
    Rev Esp Cardiol; 2010 Jul; 63(7):798-801. PubMed ID: 20609313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiologic characteristics and implications of induced ventricular fibrillation in symptomatic patients with Brugada syndrome.
    Kanda M; Shimizu W; Matsuo K; Nagaya N; Taguchi A; Suyama K; Kurita T; Aihara N; Kamakura S
    J Am Coll Cardiol; 2002 Jun; 39(11):1799-805. PubMed ID: 12039494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shock efficacy of the entirely subcutaneous defibrillator for termination of spontaneous ventricular fibrillation in Brugada syndrome.
    De Maria E; Cappelli S; Cappato R
    Heart Rhythm; 2013 Dec; 10(12):1807-9. PubMed ID: 23933298
    [No Abstract]   [Full Text] [Related]  

  • 5. Outcomes of catheter ablation in high-risk patients with Brugada syndrome refusing an implantable cardioverter defibrillator implantation.
    Li L; Ding L; Zhou L; Wu L; Zheng L; Zhang Z; Xiong Y; Zhang Z; Yao Y
    Europace; 2023 Dec; 26(1):. PubMed ID: 37889958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatial and temporal heterogeneity of depolarization and repolarization may complicate implantable cardioverter defibrillator therapy in Brugada syndrome.
    Stix G; Bella PD; Carbucicchio C; Schmidinger H
    J Cardiovasc Electrophysiol; 2000 May; 11(5):516-21. PubMed ID: 10826930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrical Substrate Elimination in 135 Consecutive Patients With Brugada Syndrome.
    Pappone C; Brugada J; Vicedomini G; Ciconte G; Manguso F; Saviano M; Vitale R; Cuko A; Giannelli L; Calovic Z; Conti M; Pozzi P; Natalizia A; Crisà S; Borrelli V; Brugada R; Sarquella-Brugada G; Guazzi M; Frigiola A; Menicanti L; Santinelli V
    Circ Arrhythm Electrophysiol; 2017 May; 10(5):e005053. PubMed ID: 28500178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mode of onset of ventricular fibrillation in patients with early repolarization pattern vs. Brugada syndrome.
    Nam GB; Ko KH; Kim J; Park KM; Rhee KS; Choi KJ; Kim YH; Antzelevitch C
    Eur Heart J; 2010 Feb; 31(3):330-9. PubMed ID: 19880418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The circadian pattern of the development of ventricular fibrillation in patients with Brugada syndrome.
    Matsuo K; Kurita T; Inagaki M; Kakishita M; Aihara N; Shimizu W; Taguchi A; Suyama K; Kamakura S; Shimomura K
    Eur Heart J; 1999 Mar; 20(6):465-70. PubMed ID: 10213350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of low-dose quinidine on ventricular tachyarrhythmias in patients with Brugada syndrome: low-dose quinidine therapy as an adjunctive treatment.
    Mizusawa Y; Sakurada H; Nishizaki M; Hiraoka M
    J Cardiovasc Pharmacol; 2006 Mar; 47(3):359-64. PubMed ID: 16633076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term outcome after cardioverter-defibrillator implantation in patients with Brugada syndrome].
    Binbin Y; Jingping L; Bing Y; Minglong C; Jiangang Z; Kejiang C; Qijun S
    Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Aug; 43(8):690-4. PubMed ID: 26955725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful radiofrequency catheter ablation for electrical storm of ventricular fibrillation in a patient with Brugada syndrome.
    Nakagawa E; Takagi M; Tatsumi H; Yoshiyama M
    Circ J; 2008 Jun; 72(6):1025-9. PubMed ID: 18503235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a Brugada syndrome case.
    Nakao Y; Suenari K; Yamashiro K; Nakagawa H; Shiode N
    BMC Cardiovasc Disord; 2020 Mar; 20(1):134. PubMed ID: 32169057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of electrophysiologic-guided therapy with Class IA antiarrhythmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome.
    Belhassen B; Viskin S; Fish R; Glick A; Setbon I; Eldar M
    J Cardiovasc Electrophysiol; 1999 Oct; 10(10):1301-12. PubMed ID: 10515552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Brugada syndrome].
    Matsuo K; Yano K
    Nihon Rinsho; 2002 Jul; 60(7):1408-14. PubMed ID: 12136622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of electrocardiographic risk markers for the initial and recurrent episodes of ventricular fibrillation in patients with Brugada syndrome.
    Morita H; Watanabe A; Kawada S; Miyamoto M; Morimoto Y; Nakagawa K; Nishii N; Nakamura K; Ito H
    J Cardiovasc Electrophysiol; 2018 Jan; 29(1):107-114. PubMed ID: 28940628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High amplitude T-wave alternans precedes spontaneous ventricular tachycardia or fibrillation in ICD electrograms.
    Swerdlow CD; Zhou X; Voroshilovsky O; Abeyratne A; Gillberg J
    Heart Rhythm; 2008 May; 5(5):670-6. PubMed ID: 18452868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of ventricular fibrillation initiation in MADIT II patients with implantable cardioverter defibrillators.
    Anthony R; Daubert JP; Zareba W; Andrews ML; McNitt S; Levine E; Huang DT; Hall WJ; Moss AJ;
    Pacing Clin Electrophysiol; 2008 Feb; 31(2):144-50. PubMed ID: 18233965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of early repolarization in inferolateral leads in Brugada patients with documented ventricular fibrillation: a novel risk factor for Brugada syndrome with ventricular fibrillation.
    Kawata H; Morita H; Yamada Y; Noda T; Satomi K; Aiba T; Isobe M; Nagase S; Nakamura K; Fukushima Kusano K; Ito H; Kamakura S; Shimizu W
    Heart Rhythm; 2013 Aug; 10(8):1161-8. PubMed ID: 23587501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seasonal and circadian distributions of ventricular fibrillation in patients with Brugada syndrome.
    Takigawa M; Noda T; Shimizu W; Miyamoto K; Okamura H; Satomi K; Suyama K; Aihara N; Kamakura S; Kurita T
    Heart Rhythm; 2008 Nov; 5(11):1523-7. PubMed ID: 18984526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.